Novuqare Pelvic Health B.V.

Novuqare Pelvic Health B.V. specializes in innovative medical technology solutions aimed at enhancing pelvic health. The company focuses on research and development in the health and nutrition sector, particularly in non-biotechnological fields. Novuqare is committed to improving healthcare through advanced medical-technological products and services. The flagship product, the MAPLe® system, utilizes high-definition electromyography (EMG) technology for pelvic floor assessment and therapy. It offers precise, real-time measurements of pelvic floor muscle activity, allowing healthcare professionals to accurately diagnose pelvic floor dysfunction. The system features 24 electrodes designed to match the anatomical variations of pelvic floor muscles, ensuring optimal measurement accuracy. It supports pelvic physiotherapy by integrating EMG, electrical stimulation, and biofeedback functionalities. Novuqare also provides extensive support, including instructional videos, expert helpdesk services, online training sessions, workshops, and advanced courses for clinicians. Novuqare's solutions are tailored for healthcare providers specializing in pelvic physiotherapy, aiming to enhance diagnostic accuracy and treatment effectiveness for patients with pelvic floor issues.

• Employees 8
• Founded 2013